[Fast-dissolving sublingual tablets of piroxicam versus naproxen in the treatment of recurrent acute osteoarthrosis. Multicenter clinical trial].

@article{Consoli1994FastdissolvingST,
  title={[Fast-dissolving sublingual tablets of piroxicam versus naproxen in the treatment of recurrent acute osteoarthrosis. Multicenter clinical trial].},
  author={Giuseppe Consoli and Maureen McCormick Covelli and Luigi di Matteo and Roberto Marcolongo and Giuseppe Tirri and Giovanni La Montagna and Vincenzo Pipitone},
  journal={Minerva medica},
  year={1994},
  volume={85 3},
  pages={89-96}
}
An open comparative study was carried out to evaluate the efficacy and safety of piroxicam FDDF, for sublingual administration, versus naproxen in the treatment of osteoarthritis. Sixty-one patients with acute-phase osteoarthritis involving various joints are reported. They were treated with 20 mg/day piroxicam FDDF or with 1000 mg/day naproxen for a total of 4 weeks. Drug efficacy was evaluated on the base of the variation of spontaneous pain, pain on motion, functional limitation and capacity… CONTINUE READING